Quazepam | Interleukin Related interleukin-related.com

Product Name :
Quazepam

Search keywords :
CD10

drugId :
null

Target Vo:
Gamma-aminobutyric acid A receptor

Target Vo Short Name :
GABAAR

Moa_Name:
Gamma-aminobutyric acid A receptor agonists

First Approval Country :
United States

First Approval Date Filter:
1985

Origin Company_Name :
Cutis Health

Active Company_Name :
Galt Pharmaceuticals LLC

Active Indication_Name:
Sleep Initiation and Maintenance Disorders

In Active Indication_Name:

Termination Status :

China Termination Status :

Highest Status:
Approved

China Highest Status:

Antibodies are immunoglobulins secreted by effector lymphoid B cells into the bloodstream. Antibodies consist of two light peptide chains and two heavy peptide chains that are linked to each other by disulfide bonds to form a “Y” shaped structure. Both tips of the “Y” structure contain binding sites for a specific antigen. Antibodies are commonly used in medical research, pharmacological research, laboratory research, and health and epidemiological research. They play an important role in hot research areas such as targeted drug development, in vitro diagnostic assays, characterization of signaling pathways, detection of protein expression levels, and identification of candidate biomarkers.
Related websites: https://www.medchemexpress.com/antibodies.html
Popular product recommendations:
Peresolimab Purity
CASP4 Antibody Protocol
Cytokeratin 19 Antibody: Cytokeratin 19 Antibody is an unconjugated, approximately 44 kDa, rabbit-derived, anti-Cytokeratin 19 polyclonal antibody. Cytokeratin 19 Antibody can be used for: WB, ELISA, IHC-P, IHC-F, Flow-Cyt, IF expriments in human, mouse, and predicted: rat, chicken, dog, pig, cow, horse, rabbit background without labeling.

Author: Interleukin Related

Related Posts